BACKGROUND: The long-term results of endocardial and percutaneous epicardial catheter ablation of ventricular tachycardia (VT) in patients with structural heart disease are disappointing. Arrhythmia recurrence after ablation and VTs with an epicardial substrate remain a clinical challenge. The purpose of this manuscript is to elaborate on feasibility and potential advantages of a surgical hybrid ablation (i.e., combined endocardial and surgical epicardial ablation) based on our initial experience consisting of five cases. METHODS: Endocardial electro-anatomical voltage and activation maps were created (Carto, Biosense Webster, California, USA), and endocardial radiofrequency (RF) applications were applied at exit sites, low voltage areas and isthmi. Next, after surgical access, epicardial voltage and activation maps were produced in combination with visual assessment of the epicardial substrate. Epicardial low voltage areas, isthmi and exit sites were identified and ablated using RF energy. RESULTS: After the procedure, VT was non-inducible in 80% of the cases (4/5, in one case no induction was performed). No peri-procedural complications occurred. After a mean follow-up of 18 months, one patient remained in sinus rhythm without, and 2 with use of antiarrhythmic drugs. One patient needed a redo procedure after 21 months, and in one patient the amiodarone dose was raised because of 2 sustained VTs. After this additional treatment, both kept sinus rhythm. CONCLUSIONS: Hybrid VT ablation is a safe and effective patient tailored procedure that comprises the major advantage of combining direct anatomical visualization and enhanced catheter stability with high-density 3D mapping. As a consequence, this procedure should be considered as a valid treatment option in complex VT management.
BACKGROUND: The long-term results of endocardial and percutaneous epicardial catheter ablation of ventricular tachycardia (VT) in patients with structural heart disease are disappointing. Arrhythmia recurrence after ablation and VTs with an epicardial substrate remain a clinical challenge. The purpose of this manuscript is to elaborate on feasibility and potential advantages of a surgical hybrid ablation (i.e., combined endocardial and surgical epicardial ablation) based on our initial experience consisting of five cases. METHODS: Endocardial electro-anatomical voltage and activation maps were created (Carto, Biosense Webster, California, USA), and endocardial radiofrequency (RF) applications were applied at exit sites, low voltage areas and isthmi. Next, after surgical access, epicardial voltage and activation maps were produced in combination with visual assessment of the epicardial substrate. Epicardial low voltage areas, isthmi and exit sites were identified and ablated using RF energy. RESULTS: After the procedure, VT was non-inducible in 80% of the cases (4/5, in one case no induction was performed). No peri-procedural complications occurred. After a mean follow-up of 18 months, one patient remained in sinus rhythm without, and 2 with use of antiarrhythmic drugs. One patient needed a redo procedure after 21 months, and in one patient the amiodarone dose was raised because of 2 sustained VTs. After this additional treatment, both kept sinus rhythm. CONCLUSIONS: Hybrid VT ablation is a safe and effective patient tailored procedure that comprises the major advantage of combining direct anatomical visualization and enhanced catheter stability with high-density 3D mapping. As a consequence, this procedure should be considered as a valid treatment option in complex VT management.
Authors: Eleanor B Schron; Derek V Exner; Qing Yao; Louise S Jenkins; Jonathan S Steinberg; James R Cook; Steven P Kutalek; Peter L Friedman; Rosemary S Bubien; Richard L Page; Judy Powell Journal: Circulation Date: 2002-02-05 Impact factor: 29.690
Authors: Christian Torp Pedersen; G Neal Kay; Jonathan Kalman; Martin Borggrefe; Paolo Della-Bella; Timm Dickfeld; Paul Dorian; Heikki Huikuri; Youg-Hoon Kim; Bradley Knight; Francis Marchlinski; David Ross; Frédéric Sacher; John Sapp; Kalyanam Shivkumar; Kyoko Soejima; Hiroshi Tada; Mark E Alexander; John K Triedman; Takumi Yamada; Paulus Kirchhof; Gregory Y H Lip; Karl Heinz Kuck; Lluís Mont; David Haines; Jukia Indik; John Dimarco; Derek Exner; Yoshito Iesaka; Irene Savelieva Journal: Heart Rhythm Date: 2014-08-30 Impact factor: 6.343
Authors: Paolo Della Bella; Josep Brugada; Katja Zeppenfeld; Jose Merino; Petr Neuzil; Philippe Maury; Giuseppe Maccabelli; Pasquale Vergara; Francesca Baratto; Antonio Berruezo; Adrianus P Wijnmaalen Journal: Circ Arrhythm Electrophysiol Date: 2011-08-13
Authors: J M de Bakker; F J van Capelle; M J Janse; S Tasseron; J T Vermeulen; N de Jonge; J R Lahpor Journal: Circulation Date: 1993-09 Impact factor: 29.690
Authors: Paul Khairy; Michael J Landzberg; Michael A Gatzoulis; Hugues Lucron; Jean Lambert; François Marçon; Mark E Alexander; Edward P Walsh Journal: Circulation Date: 2004-03-29 Impact factor: 29.690
Authors: Frédéric Sacher; Usha B Tedrow; Michael E Field; Jean-Marc Raymond; Bruce A Koplan; Laurence M Epstein; William G Stevenson Journal: Circ Arrhythm Electrophysiol Date: 2008-06-06
Authors: Pierre Jaïs; Philippe Maury; Paul Khairy; Frédéric Sacher; Isabelle Nault; Yuki Komatsu; Mélèze Hocini; Andrei Forclaz; Amir S Jadidi; Rukshen Weerasooryia; Ashok Shah; Nicolas Derval; Hubert Cochet; Sebastien Knecht; Shinsuke Miyazaki; Nick Linton; Lena Rivard; Matthew Wright; Stephen B Wilton; Daniel Scherr; Patrizio Pascale; Laurent Roten; Michala Pederson; Pierre Bordachar; François Laurent; Steven J Kim; Philippe Ritter; Jacques Clementy; Michel Haïssaguerre Journal: Circulation Date: 2012-04-04 Impact factor: 29.690
Authors: Francesco Matteucci; Mark La Meir; Bart Maesen; Gian-Battista Chierchia; Carlo De Asmundis; Sandro Gelsomino Journal: Pacing Clin Electrophysiol Date: 2021-08-02 Impact factor: 1.912